Daicel Chiral Technologies introduces Vaast: the first single-column solution for complete amino acid analysis
Strasbourg, France and West Chester, PA – the launch of VaastTM, a first-of-its-kind single-column solution for comprehensive amino acid analysis. Designed to simplify and standardize workflows, the Vaast column enables the separation of 21 natural amino acids – chiral and achiral – in a single run.
Amino acids, the fundamental building blocks of life, form the proteins and peptides that are present in every cell of every living organism. Their precise analysis is essential for progress in a wide array of fields, including pharmaceutical development, nutritional science, and metabolic research. Yet despite their importance, no single technology has ever been able to analyze natural amino acids together in one simple method, until now.
Vaast overcomes these hurdles in a first-of-its-kind method engineered for speed, reproducibility, and regulatory confidence. The single-column solution provides researchers and analysts with a robust, ready-to-use method that delivers reliable results across discovery, development, and quality control applications.
“Vaast represents the next frontier in separation science,” said Dr. Pilar Franco, PhD, President at Daicel Chiral Technologies Europe. “By simplifying what was once a multi-column process, scientists can now achieve complete enantiomer amino acid separation in minutes with a single, reliable method. It’s a complete, end-to-end solution designed to move discovery forward.”
A standout strength of the technology behind Vaast is the ability to identify chiral amino acids, which are known factors linked to illnesses such as Alzheimer’s and cancer. In fact, there are many more health conditions that may be linked in a similar way: the lack of efficient analytical tools has hindered the ability to fully investigate. By equipping researchers with the capacity to run fast and complete amino acid analysis, Vaast offers a revolutionized approach to chemical analysis that will accelerate fields including human health and drug discovery.
The Vaast Kit includes a 2.1 × 100 mm, 1.7 µm column and derivatization reagents, offering a complete start-to-finish workflow. Each kit is designed to reduce sample consumption, improve reproducibility across instruments and sites, and simplify regulatory validation with a single, standardized method, offering a complete start-to-finish workflow.
Key benefits of Vaast include:
- 5-minute LC-MS separation of 21 natural amino acids (chiral and achiral)
- Single column; single method
- Confirmed reproducibility across polar, basic, acidic, and hydrophobic amino acids
- Reduced sample waste and setup time
- Flexible use across discovery, development, and late-stage analysis
With Vaast, Daicel Chiral Technologies continues its 35-year commitment to advancing separation science through innovation, quality, and partnership.
For more information, visit chiraltech.com/vaast.
About Daicel Chiral Technologies
Daicel Chiral Technologies is the world’s most trusted source of chiral chromatography solutions for optical isomer separation. Pharmaceutical companies and academic researchers around the globe rely on Daicel’s technology to help solve their most critical separation challenges, driving innovation across drug development and scientific research.
